Loading...

DNTH DIANTHUS THERAPEUTICS INC Management Changes 8-K Filing

DNTH

DNTH

DIANTHUS THERAPEUTICS INC

(DNTH)

2025 8-K

Show Summary

Summary

Financial Statements

Financial Results

Corporate Update

Financial Results

Management Appointment

Earnings Reports

Annual Meeting of Stockholders

Earnings Reports

Earnings Reports

Private Placement

Financial Results Disclosure

Reverse Stock Split and Rev...

Earnings Reports

Appointment of New Independ...

Merger and Name Change

Departure of Directors or C...

Merger Agreement

Termination of Sublease Agr...

Stockholder Rights Plan

Financial Condition and Res...

Delisting Notice

External Links:

On March 4, 2025, Tomas Kiselak resigned from the Board of Dianthus Therapeutics, and Sujay Kango was appointed as a new director with a stock option grant of 25,000 shares and annual cash compensation of $46,000.

AI Assistant

DIANTHUS THERAPEUTICS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.